Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Argatroban is a selective thrombin inhibitor, and previous study had suggested that argatroban use post percutaneous coronary intervention could potentially prevent reocclusion. But there has no study on large sample of argatroban treated restenosis vertebral artery stenting. This study will test the safety and efficacy of the argatroban on prevent Occlusion and Restenosis in patients with Extracranial vertebral Artery Stenting.
Epistemonikos ID: b2ba630ac04b4d92801eb4d6f8346feda5df3456
First added on: May 11, 2024